|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM273585290 |
| 003 |
DE-627 |
| 005 |
20231225001547.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2017 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.201700141
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n0911.xml
|
| 035 |
|
|
|a (DE-627)NLM273585290
|
| 035 |
|
|
|a (NLM)28681981
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Xu, Xiaoding
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy
|
| 264 |
|
1 |
|c 2017
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 22.01.2019
|
| 500 |
|
|
|a Date Revised 30.09.2020
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
|
| 520 |
|
|
|a The application of nanoparticles (NPs) to drug delivery has led to the development of novel nanotherapeutics for the treatment of various diseases including cancer. However, clinical use of NP-mediated drug delivery has not always translated into improved survival of cancer patients, in part due to the suboptimal properties of NP platforms, such as premature drug leakage during preparation, storage, or blood circulation, lack of active targeting to tumor tissue and cells, and poor tissue penetration. Herein, an innovative reactive oxygen species (ROS)-responsive polyprodrug is reported that can self-assemble into stable NPs with high drug loading. This new NP platform is composed of the following key components: (i) polyprodrug inner core that can respond to ROS for triggered release of intact therapeutic molecules, (ii) polyethylene glycol (PEG) outer shell to prolong blood circulation; and (iii) surface-encoded internalizing RGD (iRGD) to enhance tumor targeting and tissue penetration. These targeted ROS-responsive polyprodrug NPs show significant inhibition of tumor cell growth both in vitro and in vivo
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a ROS-responsive
|
| 650 |
|
4 |
|a cancer therapy
|
| 650 |
|
4 |
|a polyprodrug
|
| 650 |
|
4 |
|a tumor penetrating
|
| 650 |
|
4 |
|a tumor targeting
|
| 650 |
|
7 |
|a Reactive Oxygen Species
|2 NLM
|
| 650 |
|
7 |
|a Polyethylene Glycols
|2 NLM
|
| 650 |
|
7 |
|a 3WJQ0SDW1A
|2 NLM
|
| 700 |
1 |
|
|a Saw, Phei Er
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Tao, Wei
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Li, Yujing
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ji, Xiaoyuan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Bhasin, Sushant
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Liu, Yanlan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ayyash, Dana
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Rasmussen, Jonathan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Huo, Marc
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Shi, Jinjun
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Farokhzad, Omid C
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 29(2017), 33 vom: 01. Sept.
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:29
|g year:2017
|g number:33
|g day:01
|g month:09
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.201700141
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 29
|j 2017
|e 33
|b 01
|c 09
|